Florida Administrative Code › 59 - AGENCY FOR HEALTH CARE ADMINISTRATION › 59A - Health Facility and Agency Licensing › Chapter 59A-24 - DRUG-FREE WORKPLACE STANDARDS › Section 59A-24.005 - Collection Site and Specimen Collection Procedures

Current through Reg. 50, No. 138; July 16, 2024
(1) Designation of Collection Sites. For
				urine and blood specimen collection, each laboratory, that has a contract or
				agreement for testing services with an employer, shall provide collection sites
				under contract and training for collectors, or shall provide a trained
				collector to collect specimens for the employer at any time designated by the
				employer in his contract or agreement with the laboratory. The collector shall
				be responsible to the laboratory for implementing collection procedures and
				chain of custody procedures as designated in chapter 59A-24, F.A.C. The
				laboratory shall provide to the collection site, or collector, specimen
				collection kits which, as applicable, shall contain chain of custody forms, as
				required by subsection
				59A-24.005(2),
				F.A.C., mailing boxes or containers, specimen identification labels, laboratory
				address labels, urine specimen bottles, external temperature strips,
				tamper-proof plastic sealable bags and forensic tamper-proof tape to seal the
				specimen container(s). Kits for alcohol testing must have a 7ml blood vial that
				contains an anticoagulant and a preservative of sodium fluoride. Employers who
				do not use hair testing for their drug-free workplace program shall not be
				required to maintain collection facilities and personnel as described in
				section 112.0455 (13)(b)3.a., F.S.
				Employers that choose to use hair as a specimen for testing shall meet the
				requirements found in section 112.0455(13)(b)3.a., F.S.
(2) Chain of Custody Form and Procedures.
				Chain of custody refers to the methodology of documenting the tracking of
				specified materials or substances for the purpose of maintaining control and
				accountability from initial collection to final disposition of all such
				materials or substances and providing for accountability at each stage in
				handling, testing, storing and reporting of the test results.
(a) A chain of custody form shall be
				completed for each donor tested.
(b) Each laboratory licensed under these
				rules shall provide chain-of-custody forms to be used for each donor.
(c) All chain of custody forms shall provide
				a unique identifier which shall not be used to identify any other Florida Drug
				Free Workplace specimen. The employer is permitted to assign an employee
				identification number for use with each donor tested.
(d) The design of the chain of custody forms
				shall meet the following requirements:
1.
				Prominently indicate the name and address of the laboratory performing the drug
				test(s).
2. A section to be
				completed by the collector or employer representative that solicits the
				following information:
a. Employer name and
				address;
b. Medical review officer
				name and address;
c. Employee
				identification number;
d. Reason
				for the test(s); and,
e. Test(s) to
				be performed.
3. A
				section which indicates the temperature of urine specimens taken within 4
				minutes of collection. This shall not be required for chain-of-custody forms
				for hair specimens.
4. A section to
				be completed by the collector that indicates the following:
a. The collection facility name, address and
				telephone number;
b. A designation
				that a split sample was or was not collected;
c. A remarks section;
d. A statement for the collector to sign
				incorporating the following language: I certify that the specimen identified on
				this form is the specimen presented to me or collected by me from the donor
				providing certification on Copy 4 of this form, that it bears the same
				identification number as set forth above, and that it has been collected,
				labeled and sealed in accordance with the Florida Drug-Free Workplace as found
				in sections 112.0455,
				440.102, F.S., and chapter
				59A-24, F.A.C.; and,
e. A place
				for the collector to print his name, a place for the collector's signature and
				the date and time.
5. A
				section to be initiated by the collector and completed as necessary thereafter
				that documents the transfer of the specimen for the purpose of maintaining
				control and accountability for the specimen. At a minimum, this section shall
				indicate:
a. Date of transfer;
b. Signature and name of the person releasing
				the specimen;
c. Signature and name
				of the person receiving the specimen; and,
d. Purpose of the
				transfer.
6. A section to
				be completed by the laboratory which indicates the following:
a. An indication as to whether the specimen
				was received with intact specimen seals;
b. The test results;
c. Contains the following statement for the
				certifying scientist to sign: I certify that the specimen identified by the
				laboratory accession number on this form is the same specimen that bears the
				specimen identification number set forth above, that the specimen has been
				examined upon receipt, handled and analyzed in accordance with the Florida
				Drug-Free Workplace Program requirements as found in sections
				112.0455,
				440.102, F.S., and chapter
				59A-24, F.A.C., and that the results set forth are for that specimen;
				and,
d. A place for the certifying
				scientist to print his name, the signature of the certifying scientist and the
				date.
7. A section to be
				completed by the Medical Review Officer including the following:
a. The statement: I have reviewed the
				laboratory test(s) for the specimen identified by this form in accordance with
				the Florida Drug-Free Workplace Program as found in sections
				112.0455,
				440.102, F.S., and chapter
				59A-24, F.A.C.;
b. A space for
				determination of test results as one of the following:
I. Negative;
II. Positive;
III. Test not performed; and,
IV. Test canceled.
c. A place for remarks;
d. The signature of the Medical Review
				Officer; and,
e. The name of the
				Medical Review Officer and the date.
8. The chain of custody form shall be
				comprised of the following copies for distribution:
a. Original laboratory copy (Copy 1) which
				shall be routed to the laboratory with the specimen; the laboratory will retain
				upon the completion of testing.
b.
				Second Original Laboratory copy (Copy 2) which shall be routed to the
				laboratory with the specimen; as a means of reporting the test result, the
				laboratory will forward the copy to the Medical Review Officer.
c. Split specimen copy (Copy 3) which must
				accompany the split portion to the laboratory. Split sample testing is
				optional.
d. Medical Review Officer
				copy (Copy 4) which shall be routed directly to the MRO by the collection site
				personnel; this form copy is not to be sent to the laboratory.
e. Donor copy (Copy 5) which shall be given
				to the donor by the collector. Do not send to the laboratory.
f. Collector copy (Copy 6) which shall be
				retained by the collector. Do not send to the laboratory.
g. Employer copy (Copy 7) which shall be
				forwarded to the employer.
(e) The form shall contain no information
				which can be traceable to the donor except the unique identifier, the employee
				identification number, if used, and the laboratory's specimen identification
				number.
(f) The form shall also
				contain the following list of over-the-counter and prescription drugs which
				could alter or affect a test result. Due to the large number of obscure brand
				names and constant marketing of new products, this list, as follows, is not
				intended to be all-inclusive.
Alcohol
All liquid medications containing ethyl alcohol
							 (ethanol). Please read the label for alcohol content. As an example, Vick's
							 Nyquil is 25% (50 proof) ethyl alcohol, Comtrex is 20% (40 proof), Contact
							 Severe Cold Formula Night Strength is 25% (50 proof) and Listerine is 26.9% (54
							 proof).
Amphetamines
Obetrol, Biphetamine, Desoxyn, Dexedrine, Didrex,
							 Ionamine, Fastin.
Cannabinoids
Marinol (Dronabinol, THC).
Cocaine
Cocaine HCl topical solution (Roxanne).
Phencyclidine
Not legal by prescription.
Methaqualone
Not legal by prescription.
Opiates
Paregoric, Parepectolin, Donnagel PG, Morphine,
							 Tylenol with Codeine, Empirin with Codeine, APAP with Codeine, Aspirin with
							 Codeine, Robitussin AC, Guiatuss AC, Novahistine DH, Novahistine Expectorant,
							 Dilaudid (Hydromorphone), M-S Contin and Roxanol (morphine sulfate), Percodan,
							 Vicodin, Tussi-organidin, etc.
Barbiturates
Phenobarbital, Tuinal, Amytal, Nembutal, Seconal,
							 Lotusate, Fiorinal, Fioricet, Esgic, Butisol, Mebaral, Butabarbital,
							 Butalbital, Phrenilin, Triad, etc.
Benzodiazepines
Ativan, Azene, Clonopin, Dalmane, Diazepam, Librium,
							 Xanax, Serax, Tranxene, Valium, Verstran, Halcion, Paxipam, Restoril,
							 Centrax.
Methadone
Dolophine, Metadose.
Propoxyphene
Darvocet, Darvon N, Dolene, etc.
(g)
				Handling and transportation of a specimen from one authorized individual or
				place to another shall always be accomplished through the chain of custody form
				and procedures. The chain of custody form shall be used for maintaining control
				and accountability of each specimen from the point of collection to final
				disposition of the specimen at the laboratory. The purpose of the transfer of
				possession, the name and signature of the person releasing and receiving the
				specimen, and the date shall be documented on the form each time a specimen is
				handled or transferred and every individual in the chain shall be identified.
				Since the specimen and the chain of custody form are sealed in tamper-proof
				sealable plastic bags that would indicate any tampering during transit to the
				laboratory, and since couriers, express carriers and postal service personnel
				do not have access to the chain of custody forms, there is no requirement that
				such personnel document chain of custody for the shipping container during
				transit. Nor is there a requirement that there be a chain of custody entry when
				a specimen which is sealed in such a shipping container is placed in or taken
				out of secure storage at the collection site prior to pickup by such personnel.
				A test shall not be canceled because couriers, express carriers, postal service
				personnel or other persons involved solely with the transportation of a
				specimen to a laboratory have not documented their participation in the chain
				of custody or because the chain of custody does not contain entries related to
				placing the specimen in or removing it from secure temporary storage at the
				collection site.
(h) Once the
				specimen has arrived at the laboratory, an internal chain of custody form shall
				be used by the laboratory until the laboratory has finalized the test
				results.
(i) Every effort shall be
				made to minimize the number of persons handling the
				specimens.